Baxter International (BAX) Other Non-Current Assets (2009 - 2026)
Baxter International (BAX) posted quarterly Other Non-Current Assets of $669.0 million for Q2 2026, down 22.3% year-over-year from $861.0 million in Q2 2025, and down 3.32% quarter-over-quarter from $692.0 million in Q1 2026.
Baxter International (BAX) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Other Non-Current Assets for 18 consecutive years, with $669.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Assets fell 22.3% year-over-year to $669.0 million; the TTM figure through Jun 2026 stood at $669.0 million (down 22.3% YoY), while the FY2025 annual figure was $699.0 million, down 73.23% from the prior year.
- Other Non-Current Assets slipped to $669.0 million in Q2 2026 per BAX's latest filing, from $692.0 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.9 billion in Q4 2023 and bottomed at $669.0 million in Q2 2026.
- Historically, Other Non-Current Assets has averaged $1.3 billion across 5 years, with a median of $1.1 billion in 2023.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets soared 165.92% — and 2025, when it plunged 73.23%.
- Baxter International's Other Non-Current Assets stood at $1.1 billion in 2022, then surged by 165.92% to $2.9 billion in 2023, then slipped by 11.46% to $2.6 billion in 2024, then slumped by 73.23% to $699.0 million in 2025, then decreased by 4.29% to $669.0 million in 2026.
- Business Quant data shows BAX's Other Non-Current Assets at $669.0 million in Q2 2026, $692.0 million in Q1 2026, and $699.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 452.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 669.00 Mn |
| Mar 31, 2026 | 692.00 Mn |
| Dec 31, 2025 | 699.00 Mn |
| Dec 31, 2024 | 755.00 Mn |
| Sep 30, 2024 | 2.89 Bn |
| Jun 30, 2024 | 1.14 Bn |
| Mar 31, 2024 | 1.15 Bn |
| Dec 31, 2023 | 2.95 Bn |
| Jun 30, 2023 | 233.00 Mn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | 1.24 Bn |
| Jun 30, 2022 | 1.30 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Sep 30, 2021 | 1.50 Bn |
| Jun 30, 2021 | 1.40 Bn |
| Mar 31, 2021 | 1.36 Bn |
| Dec 31, 2020 | 1.40 Bn |
| Sep 30, 2020 | 1.26 Bn |